ADSL and neoplasm: Several studies have reported the ability of animal-venom-derived AMPs to selectively target and induce apoptosis or other mechanisms of death in diverse types of tumor cells, including breast [3,4,5], lung [6], prostate [7], glioblastoma [8], and colon [9] cancer cells.